Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway

被引:56
|
作者
Ding, Jieqiong [1 ,2 ]
Tang, Qiong [1 ,2 ]
Luo, Binhua [3 ]
Zhang, Lijun [1 ]
Lin, Li [1 ]
Han, Lu [1 ]
Hao, Miaomiao [3 ]
Li, Mingyue [3 ]
Yu, Liangzhu [1 ,2 ]
Li, Mincai [1 ,2 ]
机构
[1] Hubei Univ Sci & Technol, Sch Basic Med Sci, Xianning 437100, Peoples R China
[2] Hubei Univ Sci & Technol, Hubei Key Lab Cardiovasc Cerebrovasc & Metab Diso, Xianning 437100, Peoples R China
[3] Hubei Univ Sci & Technol, Sch Pharm, Xianning 437100, Peoples R China
基金
中国国家自然科学基金;
关键词
Klotho; Hypertrophy; Fibrosis; Transforming growth factor-beta 1; Angiotensin II; LEFT-VENTRICULAR HYPERTROPHY; GROWTH-FACTOR-BETA; PROGRESSION; EXPRESSION; RECEPTORS; MODEL;
D O I
10.1016/j.ejphar.2019.172549
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent studies have revealed critical roles of transforming growth factor-beta 1 (TGF-beta 1) and microRNA-132 (miR-132), a downstream mediator of TGF-beta 1, in the pathogenesis of cardiac remodeling. In this study, we tested whether the antiaging protein klotho modifies angiotensin II (Ang II)-induced cardiac remodeling through regulating TGF-beta 1-miR-132 axis. We found that both klotho and the TGF-beta 1 inhibitor LY364947 significantly inhibited cardiac hypertrophy, fibrosis, and dysfunction in Ang II-infused mice, as evidenced by the ratios of heart weight to body weight (HW/BW), heart weight to tibial length (HW/TL), cardiomyocyte cross-sectional area, fibrotic area, and expression of prohypertrophic genes (ANP, beta-MHC) and fibrotic marker genes (alpha-SMA, collagen I), echocardiographic parameters. Meanwhile, klotho also significantly inhibited Ang II-induced protein expression of TGF-beta 1 and phosphorylated Smad2/3 in the heart tissues and cultured cardiomyocytes and cardiac fibroblasts. In vitro experiments demonstrated that Ang II-induced cardiomyocyte hypertrophy and proliferation and activation of cardiac fibroblasts were markedly inhibited by klotho, LY364947 or the miR-132 inhibitor antimiR-beta 2. Both klotho and the TGF-beta 1 inhibitor LY364947 downregulated the miR-132 expression. Additionally, klotho decreased Ang II-induced protein expressions of cardiac fibroblast growth factor (FGF)23 in vivo and in vitro. The decreased protein levels of klotho in serum and renal tissues of Ang II-infused mice were elevated by klotho. Klotho downregulated the protein levels of TGF-beta 1 in renal tissues of Ang II-infused mice. In conclusion, our results suggest that klotho prevents Ang II-induced cardiac remodeling and dysfunction through modifying the TGF-beta 1-miR-132 axis, providing an experimental basis for clinical treatment on cardiac remodeling.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway
    Yu, Liangzhu
    Meng, Wei
    Ding, Jieqiong
    Cheng, Menglin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 473 (02) : 455 - 461
  • [2] Relaxin Inhibits Angiotensin II-Induced Cardiac Fibrosis by Activating NO/cGMP Signaling Pathway
    Liu, Jie
    Pan, Defeng
    Luo, Yuanyuan
    Wu, Wanling
    Jiang, Tingbo
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2025, 29 (02): : 73 - 82
  • [3] Fibulin-2 deficiency attenuates angiotensin II-induced cardiac hypertrophy by reducing transforming growth factor-β signalling
    Zhang, Hangxiang
    Wu, Jing
    Dong, Hailong
    Khan, Shaukat A.
    Chu, Mon-Li
    Tsuda, Takeshi
    CLINICAL SCIENCE, 2014, 126 (3-4) : 275 - 288
  • [4] Klotho Inhibits Transforming Growth Factor-β1 (TGF-β1) Signaling and Suppresses Renal Fibrosis and Cancer Metastasis in Mice
    Doi, Shigehiro
    Zou, Yonglong
    Togao, Osamu
    Pastor, Johanne V.
    John, George B.
    Wang, Lei
    Shiizaki, Kazuhiro
    Gotschall, Russell
    Schiavi, Susan
    Yorioka, Noriaki
    Takahashi, Masaya
    Boothman, David A.
    Kuro-o, Makoto
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (10) : 8655 - 8665
  • [5] Tranilast inhibits angiotensin II-induced myocardial fibrosis through S100A11/transforming growth factor-β (TGF-β1)/Smad axis
    Chen, Youquan
    Huang, Ming
    Yan, Yi
    He, Dequan
    BIOENGINEERED, 2021, 12 (01) : 8447 - 8456
  • [6] The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice
    Yamazaki, Takanori
    Yamashita, Naoto
    Izumi, Yasukatsu
    Nakamura, Yasuhiro
    Shiota, Masayuki
    Hanatani, Akihisa
    Shimada, Kenei
    Muro, Takashi
    Iwao, Hiroshi
    Yoshiyama, Minoru
    HYPERTENSION RESEARCH, 2012, 35 (01) : 34 - 40
  • [7] The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice
    Takanori Yamazaki
    Naoto Yamashita
    Yasukatsu Izumi
    Yasuhiro Nakamura
    Masayuki Shiota
    Akihisa Hanatani
    Kenei Shimada
    Takashi Muro
    Hiroshi Iwao
    Minoru Yoshiyama
    Hypertension Research, 2012, 35 : 34 - 40
  • [8] Inhibition of nuclear factor-βB signaling attenuates angiotensin II-induced cardiac hypertrophy, remodeling, and apoptosis
    Sarman, B
    Skoumal, R
    Leskinen, H
    Ilves, M
    Soini, Y
    Pikkarainen, S
    Lakó-Futó, Z
    Papp, L
    Tóth, M
    Ruskoaho, H
    Szokodi, I
    CIRCULATION, 2004, 110 (17) : 21 - 21
  • [9] Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice
    Liu, Yuan
    Gao, Lu
    Guo, Sen
    Liu, Yuzhou
    Zhao, Xiaoyan
    Li, Ran
    Yan, Xiaofei
    Li, Yunpeng
    Wang, Shuai
    Niu, Xiaoyu
    Yao, Liantao
    Zhang, Yanzhou
    Li, Ling
    Yang, Haibo
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 43 (06) : 2253 - 2263
  • [10] Transforming growth factor-β activity in macrophages protects from angiotensin II-induced aortic aneurysm in mice
    Yu, Wang
    Hafid, Alt-Oufella
    Olivier, Herbin
    Jin, Huang
    Pierre-Louis, Tharaux
    Alain, Tedgui
    Ziad, Mallat
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E114 - E114